Effect of Repaglinide on Endothelial Dysfunction in Impaired Glucose Tolerance
Author Information
Author(s): Isabella Schmoelzer, Thomas C Wascher
Primary Institution: Medical University of Graz
Hypothesis
Does repaglinide reduce endothelial dysfunction during a glucose tolerance test in subjects with impaired glucose tolerance?
Conclusion
Repaglinide reduces hyperglycemia and improves endothelial dysfunction in subjects with impaired glucose tolerance.
Supporting Evidence
- Repaglinide significantly reduced plasma glucose levels at 2 hours after administration.
- Endothelial function, measured by flow-mediated dilatation, improved with repaglinide compared to control.
- The study confirmed a strong negative correlation between changes in glucose and endothelial function.
Takeaway
This study shows that a medicine called repaglinide can help people with high blood sugar feel better by lowering their blood sugar and helping their blood vessels work properly.
Methodology
A randomized, cross-over study measuring the effects of 2 mg repaglinide on glucose levels and endothelial function during an oral glucose tolerance test.
Potential Biases
The open design may introduce bias in the results.
Limitations
The sample size was small, and the study design was open-label.
Participant Demographics
12 subjects (10 males, average age 62 years, BMI 29.4 kg/m2) with impaired glucose tolerance.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website